ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma.

Abstract

BACKGROUND:

Hypoxia-inducible factor (HIF)-2α associates with poor outcome in neuroblastoma and glioblastoma, and gain-of-function mutations in the EPAS1 gene (encoding HIF-2α) have been reported in paragangliomas and pheochromocytomas. Specific targeting of a druggable hydrophobic pocket in the HIF-2α PAS-B domain with PT2385 have demonstrated promising clinical results for clear cell renal cell carcinoma (ccRCC). Here, we investigated the effect of PT2385-mediated inhibition of ARNT dependent HIF-2 activity.

METHODS:

Neuroblastoma patient-derived xenograft (PDX) cells were treated with PT2385 and analyzed for HIF-2-dependent gene expression, HIF activity, HIF-2α protein localization, response to chemotherapy and orthotopic tumor growth in vivo. Two-sided student t-test was used.

RESULTS:

We detected high levels of HIF-2α protein in perivascular niches in neuroblastoma PDXs in vivo and at oxygenated conditions in PDX-derived cell cultures in vitro, particularly in the cytoplasmic fraction. Nuclear HIF-2α expression was reduced following PT2385 treatment, but surprisingly, virtually no effects on tumor growth in vivo or expression of canonical HIF downstream target genes in vitro were observed. In coherence, RNA sequencing of PT2385-treated PDX cells revealed a virtually unaffected transcriptome. Treatment with PT2385 did not affect cellular response to chemotherapy. In contrast, HIF-2α protein knockdown resulted in profound downregulation of target genes.

CONCLUSIONS:

The lack of effect from PT2385 treatment in combination with high cytoplasmic HIF-2α expression at normoxia suggest that HIF-2α have additional roles than acting as an ARNT dependent transcription factor. It is important to further unravel the conditions at which HIF-2α has transcriptional and non-transcriptional roles in neuroblastoma.

• Authors: Camilla U Persson, Kristoffer von Stedingk, Elina Fredlund, Daniel Bexell, Sven Påhlman, Caroline Wigerup, Sofie Mohlin
• Journal: Experimental cell research (Exp Cell Res) Vol. 388 Issue 2 Pg. 111845 (03 15 2020) ISSN: 1090-2422 [Electronic] United States
• PMID: 31945318 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Chemical References

• ARNT protein, human
• Basic Helix-Loop-Helix Transcription Factors
• Biomarkers, Tumor
• Indans
• PT2385
• Sulfones
• Aryl Hydrocarbon Receptor Nuclear Translocator
• endothelial PAS domain-containing protein 1

Topics

• Animals
• Apoptosis
• Aryl Hydrocarbon Receptor Nuclear Translocator (genetics, metabolism)
• Basic Helix-Loop-Helix Transcription Factors (antagonists & inhibitors, genetics, metabolism)
• Biomarkers, Tumor (genetics, metabolism)
• Cell Proliferation
• Female
• Gene Expression Regulation, Neoplastic (drug effects)
• Humans
• Indans (pharmacology)
• Mice
• Mice, Inbred NOD
• Mice, SCID
• Neuroblastoma (genetics, metabolism, pathology)
• Sulfones (pharmacology)
• Transcriptome (drug effects)
• Tumor Cells, Cultured
• Xenograft Model Antitumor Assays